Effect of a System-Oriented Intervention on Compliance Problems in Schizophrenia: A Pragmatic Controlled Trial
Table 1
Baseline demographic and clinical characteristics.
Individual intervention, (%) Mean (SD) Median [10; 90% percentile]
Systemic intervention, (%) Mean (SD) Median [10; 90% percentile]
Number
40
30
Sex (%)
Male
17 (42.5)
14 (46.7)
Female
23 (57.5)
16 (53.3)
0.810
Age, yr (SD)
43.4 (10.6)
40.1 (10.0)
0.195
High school (%)
19 (47.5)
12 (40.0)
0.190
Education (%)
18 (45)
15 (50)
0.810
Livelihood (%)
Employed
2 (5.0)
1 (3.3)
Student
1 (2.5)
0 (0.0)
Early retirement (financed by the state)
35 (87.5)
26 (86.7)
Cash benefits
1 (2.5)
2 (6.7)
Others
1 (2.5)
1 (3.3)
0.949
Crime (%)
Arrested
10 (25.0)
9 (31.0)
0.597
New diagnosed (%)
2 (5.0)
2 (6.7)
1.000
Number of admissions
8.5 [2; 31.5]
10 [1; 50]
0.384
Duration of illness, yr
19 [4; 30]
11 [5; 32]
0.301
Abuse
Alcohol and/or drugs
10 (25.6)
14 (46.7)
0.080
Alcohol (+ drugs)
8 (20.5)
13 (43.3)
0.064
Community mental health team
26 (65.0)
21 (0.7)
0.798
Psychosocial functioning (GAF)
33 [25; 40]
33 [25; 45]
0.727
Taking medication
34 (85.0)
28 (93.3)
0.425
Medications
First-generation drug
9 (22.5)
8 (26.7)
0.781
Second-generation drug
31 (77.5)
26 (86.7)
0.371
Clozapine
10 (25.0)
10 (33.3)
0.594
Depot antipsychotics
10 (25.0)
11 (36.7)
0.307
Polypharmacy
10 (25.0)
10 (33.3)
0.594
Side effects
Physician assessment
25 (62.5)
20 (66.7)
0.804
Missing values: crime 1, number of admissions 1, duration of illness 30, abuse 1, SWN 4, PANSS, all scores 1, remission 1, GAF 2, and side effects 7. SWN: Subjective Well-Being under Neuroleptic Treatment. PANSS: Positive and Negative Symptom Scale. GAF: Global Assessment of Functioning Scale. Remission: score max 3 on all of the PANSS remission items.
